Life Science Compliance Update

August

2018

Ain’t Nobody Happy – New Jersey Attorney General Proposes Changes to Controversial Gift Regulation

Written by , Posted in Uncategorized

By: Nicodemo Fiorentino

In January 2018, a New Jersey regulation that regulates interactions between pharmaceutical manufacturers and prescribers went into effect. Now the Attorney General (“AG”) is proposing new amendments.


   or   

  • Return to July 2018 LSC Update Table of Contents
  • Copy abstract URL
  • Order Reprints
  • Topic tags:

    July

    2018

    When “Free” Really Isn’t Free – A Look at the Abiomed Case

    Written by , Posted in Uncategorized

    Robert N. Wilkey, Esq.

    In March, the United State Department of Justice (DOJ) and U.S. Attorney’s Office for the District of Massachusetts announced a $3.1 million-dollar settlement with Abiomed to resolve allegations that the company was actively using illicit marketing tactics with physicians to increase sales in a manner that violated the AKS and FCA.  Such settlement highlights that there is no such as a free lunch.


       or   

  • Return to July 2018 LSC Update Table of Contents
  • Copy abstract URL
  • Order Reprints
  • Topic tags:

    Menu Title